Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche

Digital Health Interests Of Pharma Giants Boehringer Ingelheim, Takeda, Astrazeneca, Amgen And Roche

Posted Nov 5, 2021 from

Pharmaceutical giants have the potential to shape the digital health landscape. In this series we investigated how big pharma prepares for the next level in medicine.

This third article, which will conclude the series, will peek into the digital health trends that pharma giants Boehringer Ingelheim, Takeda, AstraZeneca, Amgen and Roche have taken an interest in.


BI has also made moves to improve the patient side of the digital health equation. Takeda: pushing for digital health innovation Through TakedaSpark, Takeda aims to boost digital health innovation through new projects and partnerships.


See Topics

See Also

Next Article